ArticleThe Lancet regional health. Europe2024

Emerging MRI and biofluid biomarkers in the diagnosis and prognosis of multiple sclerosis.

Lina Anderhalten et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.